Sec Form 4 Filing - Farrell Michael J. @ RESMED INC - 2016-03-15

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Farrell Michael J.
2. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
(Last) (First) (Middle)
RESMED INC., 9001 SPECTRUM CENTER BLVD
3. Date of Earliest Transaction (MM/DD/YY)
03/15/2016
(Street)
SAN DIEGO, CA92123
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
ResMed Common Stock 03/15/2016 M( 1 ) 5,975 A $ 33.7 150,852 D
ResMed Common Stock 03/15/2016 S( 1 ) 5,975 D $ 58.57 144,877 D
ResMed Common Stock 03/16/2016 A( 3 ) 8,097 ( 4 ) A $ 0 152,974 D
ResMed Common Stock 03/16/2016 F( 5 ) 4,226 D $ 0 148,748 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
ResMed Common Stock Options $ 33.7 03/15/2016 M( 1 ) 5,975 11/11/2010( 2 ) 11/11/2017 ResMed Commmon Stock 5,975 $ 0 45,125 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Farrell Michael J.
RESMED INC.
9001 SPECTRUM CENTER BLVD
SAN DIEGO, CA92123
Chief Executive Officer
Signatures
Michael J. Farrell, Chief Executive Officer 03/17/2016
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
( 2 )Represents date options first became exercisable. Options vest 1/4 annually.
( 3 )Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted March 1, 2013, with a three-year performance period. The shares were earned and vested March 16, 2016, when the ResMed compensation committee certified performance.
( 4 )Shares earned, based on performance, at 40% of the target award.
( 5 )Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted March 1, 2013.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.